Watch Now

Gene Testing for Clinical Trials: Precision Oncology

  • Dr. Arturo Loaiza-Bonilla, MD
    Co-founder and Chief Medical Advisor

Watch Gene Testing for Clinical Trials: Precision Oncology with expert oncologist Arturo Loaiza-Bonilla, MD, who is also Massive Bio’s Co-founder and Chief Medical Officer. Submit the form on this page to watch the full event video or attend future free events on the Massive Bio Facebook page.  

Gene Testing for Clinical Trials: Precision Oncology will cover topics such as:

  • What is Precision Oncology? 
  • How Precision Oncology has improved cancer treatment
  • Role of Genomic Testing in treatment 
  • How can patients find clinical trials for biomarkers? 

Precision oncology is defined as molecular profiling of tumors to identify targetable alterations and is emerging in clinical practice. Genomic testing analyzes genes of a cancer to find these targetable alterations that can be used in the patient’s treatment. Targeted therapies have been developed in clinical trials to attack these alterations and in some cases avoid healthy cells. 

Clinical trials test these scientific advancements in cancer treatment for tumors with biomarkers identified in genomic testing. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. Cancer patients might gain access to promising drugs and innovative treatments long before they’re made available to the public.  

Gene Testing for Clinical Trials: Precision Oncology aired on Thursday, March 10th at 12:00 pm ET. Fill out the form to watch the event now. Tune in to learn about cancer clinical trials, genomic testing, how Massive Bio can help cancer patients, and more!  

Join our community
and receive our newsletter